Dr. Brent Treiger MD

Council Member Biography

Brent Treiger, M.D., has almost fifteen years of product development experience in the biotech / pharmaceutical industry and has been significantly involved in the successful development of several oncology products. Dr. Treiger’s special skills include assessing clinical trials for likelihood of success, evaluating potential markets for new technologies, to identify the best opportunities for clinical development; devising strategies (clinical development plans) to achieve rapid regulatory approval and commercial success; interacting with the FDA; and designing and conducting clinical trials (Phase I – IV). For multiple products, Dr. Treiger has designed Phase 1 programs, negotiated with the FDA at Pre-IND meetings, and prepared IND submissions, all of which have been approved on the first pass. In addition, Dr. Treiger has developed novel regulatory strategies for multiple products and obtained FDA approval at End of Phase / Pre-Phase 3 meetings. (This is me - Update Profile)

Employment History

2008 - Unspecified

Consultant, FirstLine Consulting Group

2007 - 2008

VP, Medical Affairs, BAYHILL THERAPEUTICS, INC.

2005 - 2007

Chief Medical Officer, BN Immunotherapeutics, Inc.